{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:36:01Z","timestamp":1790184961639,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.118103","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T11:16:33Z","timestamp":1594811793000},"page":"118103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["PPAR\u03b3: A turning point for irritable bowel syndrome treatment"],"prefix":"10.1016","volume":"257","author":[{"given":"Nazanin Momeni","family":"Roudsari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser-Aldin","family":"Lashgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyamin","family":"Pazoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh","family":"Momtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Abdolghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118103_bb0005","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1111\/j.1572-0241.2008.01997.x","article-title":"Predictors of patient-assessed illness severity in irritable bowel syndrome","volume":"103","author":"Spiegel","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118103_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.185.2.95","article-title":"There is only one functional somatic syndrome","volume":"185","author":"Wessely","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.lfs.2020.118103_bb0015","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3748\/wjg.v12.i18.2830","article-title":"Functional findings in irritable bowel syndrome","volume":"12","author":"Posserud","year":"2006","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.lfs.2020.118103_bb0020","first-page":"1","article-title":"Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review","author":"Roudsari","year":"2019","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.lfs.2020.118103_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/620839","article-title":"PPAR\u03b3 in inflammatory bowel disease","volume":"2012","author":"Annese","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.lfs.2020.118103_bb0030","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gut.2006.093484","article-title":"PPAR\u03b3 as a new therapeutic target in inflammatory bowel diseases","volume":"55","author":"Dubuquoy","year":"2006","journal-title":"Gut"},{"issue":"20","key":"10.1016\/j.lfs.2020.118103_bb0035","first-page":"038","article-title":"P310 a new dual-PPAR agonist (GQ-11), prevents ischemia-reperfusion damage in rats after supraceliac aorta clamping","volume":"jez148","author":"Cavalcante Silva","year":"2019","journal-title":"European Heart Journal-Cardiovascular Imaging"},{"key":"10.1016\/j.lfs.2020.118103_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/medicines6020049","article-title":"In vitro evaluation of the phytopharmacological potential of Sargassum incisifolium for the treatment of inflammatory bowel diseases","volume":"6","author":"Nyambe","year":"2019","journal-title":"Medicines"},{"key":"10.1016\/j.lfs.2020.118103_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.fct.2018.12.046","article-title":"Kiwifruit seed oil prevents obesity by regulating inflammation, thermogenesis, and gut microbiota in high-fat diet-induced obese C57BL\/6 mice","volume":"125","author":"Qu","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118103_bb0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.stem.2019.08.017","article-title":"PRDM16 maintains homeostasis of the intestinal epithelium by controlling region-specific metabolism","volume":"25","author":"Stine","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lfs.2020.118103_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/349469","article-title":"The impact of PPAR genetic variants on IBD susceptibility and IBD disease course","volume":"2012","author":"Mwinyi","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.lfs.2020.118103_bb0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1440-1746.2011.06640.x","article-title":"Visceral hypersensitivity in irritable bowel syndrome","volume":"26","author":"Kanazawa","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2020.118103_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0304-3959(01)00285-8","article-title":"Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome","volume":"93","author":"Verne","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2020.118103_bb0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2982.2006.00875.x","article-title":"Mechanisms of hypersensitivity in IBS and functional disorders","volume":"19","author":"Azpiroz","year":"2007","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.lfs.2020.118103_bb0075","doi-asserted-by":"crossref","first-page":"G1085","DOI":"10.1152\/ajpgi.00542.2011","article-title":"Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome","volume":"302","author":"Feng","year":"2012","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology."},{"key":"10.1016\/j.lfs.2020.118103_bb0080","doi-asserted-by":"crossref","first-page":"G141","DOI":"10.1152\/ajpgi.00060.2012","article-title":"Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome","volume":"303","author":"Keszthelyi","year":"2012","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.lfs.2020.118103_bb0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4142\/jvs.2004.5.4.319","article-title":"Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome","volume":"5","author":"La","year":"2004","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.lfs.2020.118103_bb0090","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.coph.2011.09.009","article-title":"The shifting interface between IBS and IBD","volume":"11","author":"Spiller","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118103_bb0095","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2009.12.049","article-title":"Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis","volume":"138","author":"Villani","year":"2010","journal-title":"Gastroenterology"},{"issue":"e9","key":"10.1016\/j.lfs.2020.118103_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2015.12.034","article-title":"Histamine receptor H1\u2013mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome","volume":"150","author":"Wouters","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118103_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/can.2016.0009","article-title":"Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes","volume":"1","author":"Russo","year":"2016","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.1016\/j.lfs.2020.118103_bb0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpain.2011.07.005","article-title":"Nerve growth factor-mediated neuronal plasticity in spinal cord contributes to neonatal maternal separation-induced visceral hypersensitivity in rats","volume":"16","author":"Tsang","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.lfs.2020.118103_bb0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jphs.2018.11.006","article-title":"Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome","volume":"139","author":"Nozu","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2020.118103_bb0120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1440-1681.12188","article-title":"Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide","volume":"41","author":"Paragomi","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2020.118103_bb0125","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3945\/jn.114.201731","article-title":"Dietary marine n\u20133 PUFAs do not affect stress-induced visceral hypersensitivity in a rat maternal separation model","volume":"145","author":"Van Diest","year":"2015","journal-title":"J. Nutr."},{"key":"10.1016\/j.lfs.2020.118103_bb0130","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/nu9121341","article-title":"A novel prebiotic blend product prevents irritable bowel syndrome in mice by improving gut microbiota and modulating immune response","volume":"9","author":"Chen","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2020.118103_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/IJPM.IJPM_544_16","article-title":"Levels of interleukins 2, 6, 8, and 10 in patients with irritable bowel syndrome","volume":"60","author":"Patel","year":"2017","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.lfs.2020.118103_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4379673","article-title":"\u03b2-Catenin regulation in sporadic colorectal carcinogenesis: not as simple as APC","volume":"2018","author":"Fredericks","year":"2018","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.lfs.2020.118103_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.52.1.91","article-title":"Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?","volume":"52","author":"Gonsalkorale","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2020.118103_bb0150","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3748\/wjg.v22.i20.4794","article-title":"Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment","volume":"22","author":"Axelrad","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118103_bb0155","first-page":"104","article-title":"Evaluation of toll-like receptor alteration in intestinal biopsies of patients with irritable bowel syndrome: a systematic review","volume":"24","author":"Aalipour","year":"2019","journal-title":"Govaresh."},{"key":"10.1016\/j.lfs.2020.118103_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbrc.2018.11.074","article-title":"Requirement of Rab21 in LPS-induced TLR4 signaling and pro-inflammatory responses in macrophages and monocytes","volume":"508","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.118103_bb0165","series-title":"Malondialdehyde (MDA) and Glutathione Peroxidase (GPx) Are Elevated in Crohns Disease-associated With Mycobacterium Avium Subspecies Paratuberculosis (MAP)","author":"Qasem","year":"2016"},{"key":"10.1016\/j.lfs.2020.118103_bb0170","first-page":"186","article-title":"Vitamin D3 induced decrease in IL-17 and malondialdehyde, and increase in IL-10 and total antioxidant capacity levels in patients with irritable bowel syndrome","volume":"15","author":"Amani","year":"2018","journal-title":"Iranian Journal of Immunology"},{"key":"10.1016\/j.lfs.2020.118103_bb0175","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00018-009-0255-4","article-title":"IL-13 downregulates PPAR-\u03b3\/heme oxygenase-1 via ER stress-stimulated calpain activation: aggravation of activated microglia death","volume":"67","author":"Liu","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2020.118103_bb0180","doi-asserted-by":"crossref","unstructured":"Tan JT, McLennan SV, Song WW, Lo LW-Y, Bonner JG, Williams PF, et al. Connective tissue growth factor inhibits adipocyte differentiation. Am. J. Phys. Cell Phys.. 2008;295:C740-C51.","DOI":"10.1152\/ajpcell.00333.2007"},{"key":"10.1016\/j.lfs.2020.118103_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5879090","article-title":"Interactions between PPAR gamma and the canonical Wnt\/beta-catenin pathway in type 2 diabetes and colon cancer","volume":"2017","author":"Lecarpentier","year":"2017","journal-title":"PPAR Res."},{"key":"10.1016\/j.lfs.2020.118103_bb0190","doi-asserted-by":"crossref","first-page":"112863","DOI":"10.1016\/j.jep.2020.112863","article-title":"Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db\/db mice targeting INS-R\/IRS-2\/PI3K\/AKT\/PPAR-\u03b3\/Glut4 signal pathway","author":"Bao","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2020.118103_bb0195","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/15230860050192350","article-title":"Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators","volume":"2","author":"Rusyn","year":"2000","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2020.118103_bb0200","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1053\/j.gastro.2007.02.032","article-title":"The role of PPAR\u03b3 on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction","volume":"132","author":"Ponferrada","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118103_bb0205","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/ATVBAHA.108.175687","article-title":"Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance","volume":"28","author":"Zhang","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.118103_bb0210","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/db08-0564","article-title":"High glucose induces toll-like receptor expression in human monocytes: mechanism of activation","volume":"57","author":"Dasu","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2020.118103_bb0215","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10620-006-3193-0","article-title":"Attenuation of colonic inflammation by PPAR\u03b3 in intestinal epithelial cells: effect on toll-like receptor pathway","volume":"51","author":"Eun","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2020.118103_bb0220","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00213-012-2662-8","article-title":"Alteration of neuropathic and visceral pain in female C57BL\/6J mice lacking the PPAR-\u03b1 gene","volume":"222","author":"Ruiz-Medina","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2020.118103_bb0225","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/bph.14339","article-title":"PPARs and pain","volume":"176","author":"Okine","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118103_bb0230","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000494412","article-title":"Irritable bowel syndrome-like symptoms in ulcerative colitis patients in clinical remission: association with residual colonic inflammation","volume":"99","author":"Ishihara","year":"2019","journal-title":"Digestion"},{"key":"10.1016\/j.lfs.2020.118103_bb0235","first-page":"101","article-title":"The pathophysiology of irritable bowel syndrome: inflammation and motor disorder","volume":"47","author":"Park","year":"2006","journal-title":"The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe chi."},{"key":"10.1016\/j.lfs.2020.118103_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8328490","article-title":"Role of inflammation in the pathogenesis of diverticular disease","volume":"2019","author":"Tursi","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2020.118103_bb0245","series-title":"Molecular Mechanisms in Irritable Bowel Syndrome: UCLA","author":"Videlock","year":"2019"},{"key":"10.1016\/j.lfs.2020.118103_bb0250","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2982.2006.00792.x","article-title":"Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse","volume":"18","author":"Coates","year":"2006","journal-title":"Neurogastroenterology & Motility"},{"key":"10.1016\/j.lfs.2020.118103_bb0255","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00436-019-06241-w","article-title":"5-HT 3A serotonin receptor in the gastrointestinal tract: the link between immune system and enteric nervous system in the digestive form of Chagas disease","volume":"118","author":"de Oliveira","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.lfs.2020.118103_bb0260","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2006.02858.x","article-title":"Intestinal serotonin signalling in irritable bowel syndrome","volume":"23","author":"Mawe","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.118103_bb0265","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/1735-5362.258489","article-title":"Anti-inflammatory effects of alosetron mediated through 5-HT3 receptors on experimental colitis","volume":"14","author":"Motavallian","year":"2019","journal-title":"Research in Pharmaceutical Sciences"},{"key":"10.1016\/j.lfs.2020.118103_bb0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy071","article-title":"Canadian Association of Gastroenterology clinical practice guideline for the management of irritable bowel syndrome (IBS)","volume":"2","author":"Moayyedi","year":"2019","journal-title":"Journal of the Canadian Association of Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118103_bb0275","first-page":"259","article-title":"Guidelines on the management of irritable bowel syndrome: in memory of professor Witold Bartnik","volume":"13","author":"Pietrzak","year":"2018","journal-title":"Przeglad Gastroenterologiczny"},{"key":"10.1016\/j.lfs.2020.118103_bb0280","first-page":"1852","article-title":"The effect of regulating molecules on the structure of the PPAR-RXR complex","volume":"1861","author":"Amber-Vitos","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.lfs.2020.118103_bb0285","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR\u03b3 partial agonism","volume":"2015","author":"Kroker","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.lfs.2020.118103_bb0290","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41467-018-04176-x","article-title":"Defining a conformational ensemble that directs activation of PPAR\u03b3","volume":"9","author":"Chrisman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2020.118103_bb0295","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"Journal of Advanced Pharmaceutical Technology & Research"},{"key":"10.1016\/j.lfs.2020.118103_bb0300","series-title":"The Effect of Conjugated Linoleic Acid and Its 9: 11 and 10: 12 Isomers on the Inflamatory Profiles on Monocytic\/Macrophage and Endothelial Cell Systems","author":"Al-Muharrami","year":"2010"},{"key":"10.1016\/j.lfs.2020.118103_bb0305","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2020.118103_bb0310","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118103_bb0315","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0165-6147(00)01559-5","article-title":"PPAR-\u03b3 agonists: therapeutic role in diabetes, inflammation and cancer","volume":"21","author":"Murphy","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2020.118103_bb0320","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1210\/en.2005-0623","article-title":"Peroxisome proliferator-activated receptor-\u03b3 transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1","volume":"147","author":"Deng","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2020.118103_bb0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-230X-10-60","article-title":"The role of T cell PPAR \u03b3 in mice with experimental inflammatory bowel disease","volume":"10","author":"Guri","year":"2010","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118103_bb0330","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/mi.2010.75","article-title":"Immunoregulatory mechanisms of macrophage PPAR-\u03b3 in mice with experimental inflammatory bowel disease","volume":"4","author":"Hontecillas","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2020.118103_bb0335","first-page":"8839","article-title":"PPAR-gamma with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD","volume":"22","author":"Vetuschi","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2020.118103_bb0340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Marion-Letellier","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118103_bb0345","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.intimp.2017.05.021","article-title":"Xanthotoxin suppresses LPS-induced expression of iNOS, COX-2, TNF-\u03b1, and IL-6 via AP-1, NF-\u03baB, and JAK-STAT inactivation in RAW 264.7 macrophages","volume":"49","author":"Lee","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2020.118103_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/260429","article-title":"The role of Nrf2-mediated pathway in cardiac remodeling and heart failure","volume":"2014","author":"Zhou","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2020.118103_bb0355","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","article-title":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders","volume":"483","author":"Agarwal","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.118103_bb0360","doi-asserted-by":"crossref","first-page":"e42777","DOI":"10.1371\/journal.pone.0042777","article-title":"Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype","volume":"7","author":"Belmonte","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118103_bb0365","doi-asserted-by":"crossref","first-page":"G1469","DOI":"10.1152\/ajpgi.00531.2006","article-title":"TLRs in the gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction","volume":"292","author":"Shibolet","year":"2007","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"issue":"e8","key":"10.1016\/j.lfs.2020.118103_bb0370","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1053\/j.gastro.2013.02.038","article-title":"Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice","volume":"144","author":"Sun","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118103_bb0375","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.clnu.2005.12.008","article-title":"CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD","volume":"25","author":"Bassaganya-Riera","year":"2006","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.lfs.2020.118103_bb0380","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.clnu.2011.04.002","article-title":"Alanyl-glutamine restores maternal deprivation-induced TLR4 levels in a rat neonatal model","volume":"30","author":"Mbodji","year":"2011","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.lfs.2020.118103_bb0385","series-title":"Actos (Pioglitazone Hydrochloride) Tablets (Prescribing Information)","author":"America","year":"2009"},{"key":"10.1016\/j.lfs.2020.118103_bb0390","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s13300-017-0273-4","article-title":"Pioglitazone and the risk of bladder cancer: a meta-analysis","volume":"8","author":"Filipova","year":"2017","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.lfs.2020.118103_bb0395","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/dme.13854","article-title":"A systematic review of observational studies of the association between pioglitazone use and bladder cancer","volume":"36","author":"Ripamonti","year":"2019","journal-title":"Diabet. Med."},{"key":"10.1016\/j.lfs.2020.118103_bb0400","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2337\/dc17-0078","article-title":"Pioglitazone improves left ventricular diastolic function in subjects with diabetes","volume":"40","author":"Clarke","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2020.118103_bb0405","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.03.19","article-title":"Pioglitazone and cardiovascular risk in T2DM patients: is it good for all?","volume":"6","author":"Abdul-Ghani","year":"2018","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.lfs.2020.118103_bb0410","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/14740338.2012.691963","article-title":"Thiazolidinedione safety","volume":"11","author":"Kung","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.lfs.2020.118103_bb0415","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1463-1326.2006.00633.x","article-title":"Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy","volume":"9","author":"Berhanu","year":"2007","journal-title":"Diabetes. Obes. Metab."},{"key":"10.1016\/j.lfs.2020.118103_bb0420","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-200932030-00002","article-title":"Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes","volume":"32","author":"Dormandy","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.lfs.2020.118103_bb0425","first-page":"914","article-title":"Pioglitazone and risk for bone fracture: safety data from a randomized clinical trial","volume":"102","author":"Viscoli","year":"2017","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.lfs.2020.118103_bb0430","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118103_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-00999-5","article-title":"The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety","volume":"19","author":"Leonard","year":"2020","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520308547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:18:10Z","timestamp":1765228690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520308547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":87,"alternative-id":["S0024320520308547"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118103","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b3: A turning point for irritable bowel syndrome treatment","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118103"}}